Revenue plummeted 76.2% year-over-year in 2025Q4, driving gross margins into negative territory at -57.5% and highlighting an inability to cover direct production costs.
| Sales/Revenue | 1.34M | 6.08M | 4.03M | 2.5M | 2.08M | 987.88K | 893.03K |
| Revenue Growth % | -77.94% | 50.8% | 60.93% | 20.67% | 110.12% | 10.62% | - |
| Cost of Goods Sold | 1.7M | 2.56M | 2.1M | 1.72M | 1.11M | 500.7K | 502.51K |
| COGS % of Revenue | 127.12% | 42.16% | 52.19% | 68.75% | 53.3% | 50.68% | 56.27% |
| Gross Profit | -363.75K | 3.52M | 1.93M | 782.79K | 969.31K | 487.19K | 390.52K |
| Gross Margin % | -27.12% | 57.84% | 47.81% | 31.25% | 46.7% | 49.32% | 43.73% |
| Gross Profit Growth % | -110.35% | 82.43% | 146.22% | -19.24% | 98.96% | 24.75% | - |
| Operating Expenses | 4.86M | 2.17M | 4.86M | 4.47M | 1.54M | 878.14K | 851.47K |
| OpEx % of Revenue | 362.41% | 35.65% | 120.49% | 178.32% | 74.3% | 88.89% | 95.35% |
| Selling, General & Admin | 3.57M | 3.94M | 3.8M | 3.44M | 836.19K | 96.72K | 100.7K |
| SG&A % of Revenue | 266.46% | 64.78% | 94.32% | 137.52% | 40.28% | 9.79% | 11.28% |
| Research & Development | 1.29M | 927.05K | 1.05M | 1.02M | 706.02K | 781.42K | 750.77K |
| R&D % of Revenue | 95.95% | 15.25% | 26.17% | 40.79% | 34.01% | 79.1% | 84.07% |
| Other Operating Expenses | 0 | -2.7M | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.22M | 1.35M | -2.93M | -3.68M | -572.9K | -390.95K | -460.95K |
| Operating Margin % | -389.53% | 22.19% | -72.67% | -147.07% | -27.6% | -39.57% | -51.62% |
| Operating Income Growth % | -487.35% | 146.04% | 20.47% | -543.02% | -46.54% | 15.19% | - |
| EBITDA | -5.11M | 1.45M | -2.87M | -3.67M | -567.85K | -387.43K | -457.22K |
| EBITDA Margin % | -380.85% | 23.79% | -71.17% | -146.38% | -27.36% | -39.22% | -51.2% |
| EBITDA Growth % | -453.27% | 150.4% | 21.76% | -545.71% | -46.57% | 15.26% | - |
| D&A (Non-Cash Add-back) | 116.36K | 97.21K | 60.65K | 17.21K | 5.06K | 3.52K | 3.73K |
| EBIT | -5.22M | -1.35M | -2.93M | -3.68M | -572.9K | -390.95K | -460.95K |
| Net Interest Income | -51.64K | 102.36K | 220.01K | -4.5K | -251.32K | -249.39K | -87.3K |
| Interest Income | 0 | 110.08K | 251.72K | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 7.71K | 31.72K | 4.5K | 251.32K | 249.39K | 87.3K |
| Other Income/Expense | -184.9K | -2.58M | 220.01K | -4.5K | -251.32K | -249.39K | -87.3K |
| Pretax Income | -5.41M | -1.23M | -2.71M | -3.69M | -824.22K | -640.34K | -548.25K |
| Pretax Margin % | -403.31% | -20.3% | -67.22% | -147.25% | -39.71% | -64.82% | -61.39% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 87.3K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | -15.92% |
| Net Income | -5.41M | -1.23M | -2.71M | -3.69M | -824.22K | -640.34K | -548.24K |
| Net Margin % | -403.31% | -20.3% | -67.22% | -147.42% | -39.71% | -64.82% | -61.39% |
| Net Income Growth % | -338.4% | 54.46% | 26.63% | -348.04% | -28.72% | -16.8% | - |
| Net Income (Continuing) | -5.41M | -1.23M | -2.71M | -3.69M | -824.22K | -640.34K | 0 |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.67 | -0.16 | -0.34 | -0.46 | -0.27 | -0.09 | -0.09 |
| EPS Growth % | -318.75% | 52.94% | 26.09% | -70.37% | -206.82% | -0.69% | - |
| EPS (Basic) | -0.67 | -0.16 | -0.34 | -0.46 | -0.27 | -0.09 | -0.09 |
| Diluted Shares Outstanding | 8.03M | 7.95M | 7.91M | 8M | 3.08M | 7.28M | 7.28M |
| Basic Shares Outstanding | 8.03M | 7.88M | 7.91M | 8M | 3.08M | 7.28M | 7.28M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
Lumpy defense contract dependency
As indicated by the most recent quarterly data, MTEK experienced a severe revenue contraction of 76.2% year-over-year, highlighting the extreme sensitivity of the firm's top-line performance to the timing of non-recurring defense procurement cycles and the absence of a stable, recurring revenue stream.
The dramatic decline in quarterly revenue from $3.6 million in 2023Q4 to $634.2K in 2025Q4 suggests that the company's business model is currently failing to bridge the gap between major project awards. This volatility implies that the firm lacks the commercial scale necessary to maintain consistent growth, leaving it highly exposed to the unpredictable nature of government-led procurement timelines.
According to the latest financial statements, MTEK's gross margin plummeted to -57.5% in 2025Q4, a stark reversal from the 59.3% margin reported in 2024Q4, which suggests that the company is currently unable to cover its direct manufacturing costs at current production volumes.
This negative margin profile indicates that the company may be suffering from significant under-absorption of fixed manufacturing overhead or potentially high costs associated with specialized component procurement. Investors should monitor whether this margin compression is a temporary result of inventory write-downs or a structural issue stemming from an inability to achieve economies of scale in its niche hardware segment.
Based on reported figures, MTEK's operating income has deteriorated to a loss of $2.9 million in 2025Q4, demonstrating that the company's high fixed-cost structure, particularly in R&D and SG&A, is not scaling effectively against the current, significantly diminished revenue base.
The inability to reduce operating expenses in proportion to the sharp revenue decline suggests a lack of operational flexibility. This persistent operating loss warrants further investigation into management's ability to right-size the cost base without compromising the technical R&D capabilities that form the company's core value proposition.
As evidenced by the consistent net losses and the recent drop in revenue, the company's current financial trajectory appears unsustainable, with the $2.5 million cash position likely providing a limited runway if the firm cannot secure a major, high-margin contract in the near term.
Short-sellers would likely focus on the disconnect between the company's specialized technical niche and its inability to convert that expertise into profitable, repeatable sales. The reliance on equity-based funding to cover operational burn suggests that shareholders face significant dilution risk if the current revenue trough persists.
Quick answers to the most common questions about buying MTEK stock.
For fiscal year 2025, Maris-Tech Ltd. (MTEK) reported total revenue of $1.3M. This represents a 50.2% increase compared to $0.9M in 2019.
Maris-Tech Ltd. (MTEK) reported a net loss of $5.4M for the fiscal year ending 2025.
Maris-Tech Ltd. (MTEK) reported an operating income of $-5.2M, resulting in an operating profit margin of -389.5%. This margin reflects the operational efficiency of the business before interest and taxes.
Maris-Tech Ltd. (MTEK) generated $-0.4M in gross profit for the year, representing a gross profit margin of -27.1%. This demonstrates the company's core pricing power and production efficiency.